Company: AEMD
Filing Date: 2025-09-05
Form Type: 424B4
Source: 0001683168-25-006701
Chunk: 32

Company: AETHLON MEDICAL INC
Filing Date: 2025-09-05
Form: 424B4
Chunk 32
---
| · | No public market exists                                                                                                     
 for the offered warrants or pre-funded warrants, limiting their liquidity and value.                                        |
| · | We will not receive meaningful                                                                                              
 funds upon the exercise of pre-funded warrants.                                                                             |
| · | Pre-funded warrants are                                                                                                     
 subject to beneficial ownership limits, potentially preventing holders from exercising when it is financially advantageous. |

Reverse Stock Split

On June
6, 2025, the Company completed a reverse split of its outstanding shares of common stock at a ratio of 1-for-8. In connection with the
reverse stock split, every 8 shares of the Company’s issued and outstanding common stock was automatically converted into one share
of the Company’s common stock. Any fractional shares resulting from the reverse split were rounded up to the next whole share.
All common stock amounts and prices in this Offering Circular reflect the consummation of the reverse split.

Our Corporate Information

On March
10, 1999, Aethlon, Inc., a California corporation, Hemex, Inc., a Delaware corporation and the accounting predecessor to Aethlon, Inc.,
and Bishop Equities, Inc., a publicly traded Nevada corporation, completed an Agreement and Plan of Reorganization structured to result
in Bishop Equities, Inc.’s acquisition of all of the outstanding common stock of Aethlon, Inc. and Hemex, Inc. Under the plan’s
terms, Bishop Equities, Inc. issued shares of its common stock to the stockholders of Aethlon, Inc. and Hemex, Inc. such that Bishop
Equities, Inc. then owned 100% of each company. Upon completion of the transaction, Bishop Equities, Inc. was renamed Aethlon Medical,
Inc. Our executive offices are located at 11555 Sorrento Valley Road, Suite 203, San Diego, California 92121. Our telephone number is
(619) 941-0360. Our website address is www.aethlonmedical.com. The information contained on, or that can be accessed through, our website
is not part of, and is not incorporated into, this prospectus, and you should not rely on any such information in making the decision
of whether to purchase our securities.

| 17 |

Smaller Reporting Company

We are
a “smaller reporting company” as defined in Rule 12b-2 of the Securities Exchange Act of 1934, as amended, or the Exchange
Act, and have elected to take advantage